Personal genetics specialist, 23andMe received a nod from FDA for a genetic health risk report on a hereditary colorectal cancer syndrome. FDAs nod for the Mountain View, CA-based companys MUTYH-Associated Polyposis Genetic Health Risk repor... Read More >

A simple blood test could help detect whether a newly transplanted lung is being rejected by a patient, even when there arent any apparent signs of rejection. The donor-derived cell-free DNA test was developed by the National Institutes of H... Read More >

Researchers in the Stanford lab of Stephen Quake are using single cell RNA sequencing (scRNA-seq) in an effort to provide insight into food allergies and the antibodies that cause them. The results from their research were recently published... Read More >

Danaher today announced a 5 percent year-over-year increase in its fourth quarter revenues, beating the consensus Wall Street estimate. For the three months ended Dec. 31, 2018, the Washington-based conglomerate posted $5.36 billion in reven... Read More >

MilliporeSigma and Roche announced today that they have renewed a global distribution agreement for certain reagents and qPCR products. The agreement covers the distribution of Roches biochemical reagents and Kapa Biosystems portfolios, and... Read More >

The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of close to 14% during the period 2019-2023, driven mainly by the growing number of MAs and collaborations, and rising focus on next-generation product... Read More >

Luminex Corporation (Austin, Texas, USA) has completed its previously announced acquisition of MilliporeSigmas (Burlington, MA, USA) flow cytometry portfolio. Luminex offers a wide range of solutions applicable in diverse markets, including... Read More >

The US Food and Drug Administration today granted de novo clearance that permits marketing of Hologics Aptima assay for Mycoplasma genitalium sexually-transmitted infection in men and women. The FDA said that this is the first test it has au... Read More >

The global urinalysis market is expected to grow at a steady CAGR of 5.40% over the 2016-2024 period to reach a value of USD 1.5 billion by the end of 2024, propelled mainly by the rising incidence of diabetes and urinal infections, globally... Read More >

Beckman Coulter (Brea, CA, USA) has launched the ClearLLab 10C System for clinical flow cytometry labs that includes the first 10-color CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages. The four ClearLLab 10... Read More >